Stroke-Related Specific Mortality and Influencing Factors in Patients with Atrial Fibrillation in the RE-LY Trial

被引：0
|
作者：
Le Heuzey, Jean-Yves [1 ]
Marijon, Eloi [1 ]
Connolly, Stuart [2 ]
Brueckmann, Martina [3 ]
Yang, Sean [2 ]
Pogue, Janice [2 ]
Eikelboom, John [2 ]
Ezekowitz, Michael [4 ]
Themeles, Ellison [2 ]
Wallentin, Lars [5 ]
Yusuf, Salim [2 ]
机构：
[1] Hop Europeen Georges Pompidou, Paris, France
[2] Populat Hlth Rsch Inst, Hamilton, ON, Canada
[3] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[4] Cardiovasc Rsch Fdn, Wynnewood, PA USA
[5] Uppsala Clin Rsch Cntr, Uppsala, Sweden
来源：
STROKE | 2013年 / 44卷 / 02期
关键词：
Sudden cardiac death; Heart failure; Embolism; Anticoagulation; Atrial fibrillation;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis
    Kloosterman, Marielle
    Oldgren, Jonas
    Conen, David
    Wong, Jorge A.
    Connolly, Stuart J.
    Avezum, Alvaro
    Yusuf, Salim
    Ezekowitz, Michael D.
    Wallentin, Lars
    Ntep-Gweth, Marie
    Joseph, Philip
    Barrett, Tyler W.
    Tanosmsup, Supachai
    McIntyre, William F.
    Lee, Shun Fu
    Parkash, Ratika
    Amit, Guy
    Grinvalds, Alex
    Van Gelder, Isabelle C.
    Healey, Jeff S.
    EUROPACE, 2020, 22 (06): : 870 - 877
  • [32] Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE-LY Trial
    Hijazi, Ziad
    Verdecchia, Paolo
    Oldgren, Jonas
    Andersson, Ulrika
    Reboldi, Gianpaolo
    Di Pasquale, Giuseppe
    Mazzotta, Giovanni
    Angeli, Fabio
    Eikelboom, John W.
    Ezekowitz, Michael D.
    Connolly, Stuart J.
    Yusuf, Salim
    Wallentin, Lars
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (02):
  • [33] Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation Results From the RE-LY Trial
    Stam-Slob, Manon C.
    Connolly, Stuart J.
    van der Graaf, Yolanda
    van der Leeuw, Joep
    Dorresteijn, Jannick A. N.
    Eikelboom, John W.
    Peters, Ron J. G.
    Alings, Marco
    Visseren, Frank L. J.
    CIRCULATION, 2019, 139 (25) : 2846 - 2856
  • [34] RE-LY trial: new sub-analyses highlight stroke reduction in all types of non-valvular atrial fibrillation
    不详
    CARDIOVASCULAR JOURNAL OF AFRICA, 2011, 22 (03) : 164 - 164
  • [35] Alcohol Consumption and Cardiovascular Outcomes in Patients With Atrial Fibrillation; a RE-LY AF Registry Analysis
    Oraii, Alireza
    Kirabo, Faith
    Balasubramanian, Kumar
    Benz, Alexander P.
    Wong, Jorge A.
    McIntyre, William F.
    Conen, David
    Healey, Jeff S.
    CIRCULATION, 2022, 146
  • [36] Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy
    Hijazi, Ziad
    Oldgren, Jonas
    Andersson, Ulrika
    Connolly, Stuart J.
    Ezekowitz, Michael D.
    Hohnloser, Stefan H.
    Reilly, Paul A.
    Siegbahn, Agneta
    Yusuf, Salim
    Wallentin, Lars
    HEART, 2014, 100 (15) : 1193 - 1200
  • [37] The CHADS2 Components Are Associated with Stroke-Related In-hospital Mortality in Patients with Atrial Fibrillation
    Yaghi, Shadi
    Sherzai, Ayesha
    Pilot, Markeith
    Sherzai, Dean
    Elkind, Mitchell S. V.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (10): : 2404 - 2407
  • [38] Impact of Atrial Fibrillation on Stroke-Related Healthcare Costs
    Sussman, Matthew
    Lin, Iris
    Kwong, Winghan J.
    Lee, Lauren
    Munsell, Michael
    Friedman, Mark
    Selim, Magdy
    Menzin, Joseph
    ANNALS OF NEUROLOGY, 2013, 74 : S2 - S2
  • [39] Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial
    Alak, Aiman
    Hohnloser, Stefan H.
    Fraessdorf, Mandy
    Reilly, Paul
    Ezekowitz, Michael
    Healey, Jeff S.
    Brueckmann, Martina
    Yusuf, Salim
    Connolly, Stuart J.
    EUROPACE, 2019, 21 (07): : 1023 - 1038
  • [40] Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial
    Oldgren, Jonas
    Alings, Marco
    Darius, Harald
    Diener, Hans-Christoph
    Eikelboom, John
    Ezekowitz, Michael D.
    Kamensky, Gabriel
    Reilly, Paul A.
    Yang, Sean
    Yusuf, Salim
    Wallentin, Lars
    Connolly, Stuart J.
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (10) : 660 - +
12345